Stevanato Group strengthens its collaboration with Microsoft Italy in support of its growth program through the use of new technologies to meet the challenges the pharmaceutical industry is currently experiencing as a result of the pandemic. The Group, which has over 4,200 employees and 14 production facilities in 9 countries, is playing a key role in the production of plastic components for diagnostic tests and glass primary packaging for drugs.
